Hildebrandt, J.; Häfner, N.; Kritsch, D.; Görls, H.; Dürst, M.; Runnebaum, I.B.; Weigand, W.
Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms. Int. J. Mol. Sci. 2022, 23, 4976.
https://doi.org/10.3390/ijms23094976
AMA Style
Hildebrandt J, Häfner N, Kritsch D, Görls H, Dürst M, Runnebaum IB, Weigand W.
Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms. International Journal of Molecular Sciences. 2022; 23(9):4976.
https://doi.org/10.3390/ijms23094976
Chicago/Turabian Style
Hildebrandt, Jana, Norman Häfner, Daniel Kritsch, Helmar Görls, Matthias Dürst, Ingo B. Runnebaum, and Wolfgang Weigand.
2022. "Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms" International Journal of Molecular Sciences 23, no. 9: 4976.
https://doi.org/10.3390/ijms23094976
APA Style
Hildebrandt, J., Häfner, N., Kritsch, D., Görls, H., Dürst, M., Runnebaum, I. B., & Weigand, W.
(2022). Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms. International Journal of Molecular Sciences, 23(9), 4976.
https://doi.org/10.3390/ijms23094976